Curis Operating Income Over Time
| CRIS Stock | USD 1.11 0.03 2.63% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Curis Performance and Curis Correlation. Is there potential for Biotechnology market expansion? Will Curis introduce new products? Factors like these will boost the valuation of Curis. Projected growth potential of Curis fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Curis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.30) | Revenue Per Share | Quarterly Revenue Growth 0.084 | Return On Assets | Return On Equity |
Curis Inc's market price often diverges from its book value, the accounting figure shown on Curis's balance sheet. Smart investors calculate Curis' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Curis' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Curis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Curis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Curis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare Curis Inc and related stocks such as Entero Therapeutics, Processa Pharmaceuticals, and Briacell Therapeutics Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PCSA | (160 K) | (770 K) | (2.3 M) | (3 M) | (4.2 M) | (987.2 K) | 2.7 M | (1.8 M) | (4.5 M) | (3.9 M) | (15.1 M) | (12.1 M) | (27.5 M) | (11.5 M) | (12.1 M) | (10.8 M) | (10.3 M) |
| BCTX | (8.6 K) | (559.6 K) | (290.1 K) | (476.5 K) | (1.9 M) | (2.2 M) | (3.2 M) | (5 M) | (6.3 M) | (4.8 M) | (8.9 M) | (19.4 M) | (31.3 M) | (45.5 M) | (37.7 M) | (34 M) | (32.3 M) |
| CTXR | (25.6 K) | (19.6 K) | (28.1 K) | (1.2 M) | (3.2 M) | (7.4 M) | (10 M) | (13.8 M) | (15.6 M) | (17.7 M) | (23.5 M) | (33.3 M) | (36.7 M) | (42 M) | (38.5 M) | (34.7 M) | (32.9 M) |
| PALI | (1.6 M) | (13 M) | (10.2 M) | (12.5 M) | (17.4 M) | (19.2 M) | (20.2 M) | (13.2 M) | (8.3 M) | (8.6 M) | (9.3 M) | (41.9 M) | (15.7 M) | (13.1 M) | (14.9 M) | (13.4 M) | (14 M) |
| ASBP | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (976.3 K) | (1.3 M) | (3.1 M) | (2.8 M) | (2.6 M) |
| HOTH | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (2.5 M) | (7.7 M) | (7.3 M) | (14.1 M) | (11.1 M) | (7.7 M) | (8.2 M) | (7.4 M) | (7.8 M) |
| ICU | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (4.4 M) | (11.6 M) | (14.2 M) | (17.8 M) | (16.1 M) | (16.9 M) |
Curis Inc and related stocks such as Entero Therapeutics, Processa Pharmaceuticals, and Briacell Therapeutics Operating Income description
Operating Income is the amount of profit realized from Curis Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Curis Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Curis Inc | CRIS |
| Classification | Cancer Fighters |
| Business Address | Building C, Lexington, |
| Exchange | NASDAQ Exchange |
USD 1.11
Additional Tools for Curis Stock Analysis
When running Curis' price analysis, check to measure Curis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curis is operating at the current time. Most of Curis' value examination focuses on studying past and present price action to predict the probability of Curis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curis' price. Additionally, you may evaluate how the addition of Curis to your portfolios can decrease your overall portfolio volatility.